Annals of Emergency Medicine
Volume 44, Issue 4 , Pages 330-341 , October 2004

Care of the renal transplant recipient in the emergency department

  • K.K. Venkat, MD
    • ,
  • Arvind Venkat, MD

      Affiliations

    • Corresponding Author InformationAddress for correspondence: Arvind Venkat, MD, Department of Emergency Medicine, University of Cincinnati College of Medicine, PO Box 670769, 231 Albert Sabin Way, Cincinnati, OH 45267-0769; 513-558-5281, fax 513-558-5791;

Received 11 March 2004 ,Revised 17 May 2004 ,Accepted 24 May 2004.

References 

  1. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341:1725–1730
  2. Meier-Kriesche H, Ojo AO, Port FK, et al. Survival improvement among patients with end-stage renal disease: trends over time for transplant recipients and wait-listed patients. J Am Soc Nephrol. 2001;12:1293–1296
  3. Djamali A, Kendziorski C, Brazy PC, et al. Disease progression and outcomes in chronic kidney disease and renal transplantation. Kidney Int. 2003;64:1800–1807
  4. Randall HB, Cao S, de Vera ME. Transplantation in elderly patients. Arch Surg. 2003;138:1089–1092
  5. Collins AJ, Kasiske B, Herzog C, et al. Excerpts from the United States Renal Data System 2003 Annual Data Report: atlas of end-stage renal disease in the United States. Am J Kidney Dis. 2003;42(Suppl 5):A5–A7
  6. Suthanthiran M, Strom TB. Medical progress: renal transplantation. N Engl J Med. 1994;331:365–376
  7. Mange KC, Joffe MM, Feldman HI. Effect of use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors. N Engl J Med. 2001;344:726–731
  8. Denton MD, Magee CM, Sayegh MH. Immunosuppressive strategies in transplantation. Lancet. 1999;353:1083–1091
  9. Schwartz SI. Principles of Surgery. 6th ed.. New York, NY: McGraw-Hill; 1994;
  10. Takai K, Kishi Y, Fujikawa K, et al. Delayed graft function after renal transplantation from non-heart beating donors. Transplant Proc. 2003;35:89–91
  11. Gonwa T, Johnson C, Ahsan N, et al. Randomized trial of tacrolimus+mycophenolate mofetil or azathioprine versus cyclosporine+mycophenolate mofetil after cadaveric kidney transplantation: results at three years. Transplantation. 2003;75:2048–2053
  12. Johnson RWG. Sirolimus (Rapamune) in renal transplantation. Curr Opin Nephrol Hypert. 2002;11:603–607
  13. Vincenti F. Immunosuppression minimization: current and future trends in transplant immunosuppression. J Am Soc Nephrol. 2003;14:1940–1948
  14. Goggins WC, Pascual MA, Powelson JA, et al. A prospective, randomized clinical trial of intraoperative versus postoperative thymoglobulin in adult cadaveric renal transplant recipients. Transplantation. 2003;76:798–802
  15. Szczech LA, Feldman HI. Effect of anti-lymphocyte antibody induction therapy on renal allograft survival. Transplant Proc. 1999;31(3B Suppl):9S–11S
  16. Danovitch DM. Immunosuppressive medications and protocols for kidney transplantation. In:  Danovitch GM editors. Handbook of Transplantation. 3rd ed.. Philadelphia, PA: Lippincott Williams & Wilkins; 2001;p. 62–110
  17. McDougal BA, Whittier FC, Cross DE. Sudden death after bolus steroid therapy for rejection. Transplant Proc. 1976;8:493–496
  18. Seifedlin R. Drug interactions in transplantation. Clin Ther. 1995;17:1043–1061
  19. Mignat C. Clinically significant drug interactions with new immunosuppressive agents. Drug Safety. 1997;16:267–278
  20. Levy GA. Long-term immunosuppression and drug interactions. Liver Transplant. 2001;7(part 2):S53–S59
  21. Asberg A. Interactions between cyclosporin and lipid-lowering drugs: implications for organ transplant recipients. Drugs. 2003;63:367–378
  22. Nickeleit V, Singh HK, Mihatsch MJ. Polyomavirus nephropathy: morphology, pathophysiology, clinical management. Curr Opin Nephrol Hypert. 2003;12:599–605
  23. Thadhani R, Pascual M, Bonventre JV. Medical progress: acute renal failure. N Engl J Med. 1996;334:1448–1460
  24. Morales JM, Andres A, Prieto C, et al. Fractional excretion of sodium during acute rejection superimposed on acute tubular necrosis in the immediate posttransplant period. Transpl Proc. 1988;20(Suppl 6):63–65
  25. Hricak H, Cruz C, Eyler WR, et al. Acute posttransplantation renal failure: differential diagnosis by ultrasound. Radiology. 1981;139:441–449
  26. Barrientos A, Leiva O, Diaz-Gonzalez R, et al. The value of ultrasonic scanning in the differentiation of acute posttransplant renal failure. J Urol. 1981;126:308–312
  27. Murphy AM, Robertson RJ, Dubbins PA. Duplex ultrasound in the assessment of renal transplant complications. Clin Radiol. 1987;38:229–234
  28. Buckley AR, Cooperberg PL, Reeve CE, et al. The distinction between acute renal transplant rejection and cyclosporine nephrotoxicity: value of duplex sonography. Amer J Roentgenol. 1987;149:521–525
  29. Nankivell BJ, Borrows RJ, Fung CLS, et al. The natural history of chronic allograft nephropathy. N Engl J Med. 2003;349:2326–2333
  30. Briganti EM, Russ GR, Mcneil JJ, et al. Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med. 2002;347:103–109
  31. Brown PD. Urinary tract infections in renal transplant recipients. Curr Infect Dis Rep. 2002;4:525–528
  32. Munoz P. Management of urinary tract infection and lymphocele in renal transplant recipients. Clin Infect Dis. 2001;33(Suppl 1):S53–S57
  33. Gritsch HA, Rosenthal JT. The transplant operation and its surgical complications. In:  Danovitch GM editors. Handbook of Transplantation. 3rd ed.. Philadelphia, PA: Lippincott Williams & Wilkins; 2001;p. 146–162
  34. Patel NH, Jindal RM, Wilkin T, et al. Renal arterial stenosis in renal allografts: retrospective study of predisposing factors and outcome after percutaneous transluminal angioplasty. Radiology. 2001;219:663–667
  35. Rengel M, Gomes-Da-Silva G, Inchaustegui L, et al. Renal artery stenosis after kidney transplantation: diagnostic and therapeutic approach. Kidney Int. 1998;54(Suppl 68):S99–S106
  36. Soler R, Perez-Fontan FJ, Lago M, et al. Renal allograft rupture: diagnostic role of ultrasound. Nephrol Dial Transpl. 1992;7:871–874
  37. Kittredge RD, Brensilver J, Pierce JC. Computed tomography in renal transplant problems. Radiology. 1978;127:165–169
  38. Tannen RL. Potassium disorders. In:  Kokko JP,  Tannen RL editor. Fluid and Electrolytes. 2nd ed.. Philadelphia, PA: WB Saunders; 1990;p. 195–300
  39. Gottlieb RH, Voci SL, Cholewski SP, et al. Urine leaks in renal transplant patients: diagnostic usefulness of sonography and renography. Clin Imaging. 1999;23:35–39
  40. Fahlenkamp D, Raatz D, Schonberger B, et al. Laparoscopic lymphocele drainage after renal transplantation. J Urol. 1993;150:316–318
  41. Pappas P, Giannopoulos A, Stravodimos KG, et al. Obstructive uropathy in the transplanted kidney: definitive management with percutaneous nephrostomy and prolonged ureteral stenting. J Endourol. 2001;15:719–723
  42. Bosma RJ, van Driel MF, van Son WJ, et al. Endourological management of ureteral obstruction after renal transplantation. J Urol. 1996;156:1099–1100
  43. Fishman JA, Rubin RH. Medical progress: infection in organ transplant recipients. N Engl J Med. 1998;338:1741–1751
  44. Sia IG, Paya CV. Infectious complications following renal transplantation. Surg Clin North Am. 1998;78:95–112
  45. Tanphaichitr NT, Brennan DC. Infectious complications in renal transplant recipients. Adv Renal Replac Ther. 2000;7:131–146
  46. Brennan DC. Cytomegalovirus in renal transplantation. J Am Soc Nephrol. 2001;12:848–855
  47. Schnitzler MA, Lowell JA, Hmiel SP, et al. Cytomegalovirus disease after prophylaxis with ganciclovir in renal transplantation: the importance of HLA-DR matching. J Am Soc Nephrol. 2003;14:780–785
  48. Loren AW, Porter DL, Stadtmauer EA, et al. Posttransplant lymphoproliferative disorder: a review. Bone Marrow Transpl. 2003;31:145–155
  49. Rigatto C. Clinical epidemiology of cardiac disease in renal transplant recipients. Semin Dialysis. 2003;16:106–110
  50. Kasiske BL. Cardiovascular disease after renal transplantation. Semin Nephrol. 2000;20:176–187
  51. Zhang R, Leslie B, Boudreaux JP, et al. Hypertension after kidney transplantation: impact, pathogenesis, and therapy. Am J Med Sci. 2003;325:202–208
  52. Johnson PC, Hogg KM, Sarosi GA. The rapid diagnosis of pulmonary infections in solid organ transplant recipients. Semin Respir Infect. 1990;5:2–9
  53. Marshall W, Foster RS, Winn W. Legionnaires' disease in renal transplant patients. Am J Surg. 1981;141:423–429
  54. Moore EH, Webb WR, Amend WJC. Pulmonary infections in renal transplantation: patients treated with cyclosporine. Radiology. 1988;167:97–103
  55. Singer SJ, Tiernan R, Sullivan EJ, et al. Interstitial pneumonitis associated with sirolimus therapy in renal transplant recipients. N Engl J Med. 2000;343:1815–1816
  56. Kleinegger CL, Stewart C, McGinnis JP. Oral complications associated with the use of immunosuppressive agents in renal transplant patient. Miss Dent Assoc J. 1996;52:20–22
  57. de Francisco AL. Gastrointestinal disease and the kidney. Eur J Gastroenterol Hepatol. 2002;14(Suppl 1):S11–S15
  58. Abou-Saif A, Lewis JH. Gastrointestinal and hepatic disorders in end-stage renal disease and renal transplant recipients. Adv Renal Replace Ther. 2000;7:220–230
  59. Weir MR, Kirkman RL, Strom TB, et al. Liver disease in recipients of long-functioning renal allografts. Kidney Int. 1985;28:839–844
  60. Fabrizi F, Martin P, Ponticelli C. Hepatitis C virus infection and renal transplantation. Am J Kidney Dis. 2001;38:919–934
  61. Uchida H, Morioka H, Ogawa N, et al. Biliary tract complications in renal allograft recipients: two case reports. Transplant Proc. 2000;32:1898–1900
  62. Sinha S, Jha R, Lakhtakia S, et al. Acute pancreatitis following kidney transplantation: role of viral infections. Clin Transplant. 2003;17:32–36
  63. Slakey DP, Johnson CP, Cziperle DJ, et al. Management of severe pancreatitis in renal transplant recipients. Ann Surg. 1997;225:217–222
  64. Bechstein WO. Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl Int. 2000;13:313–326
  65. Thistlethwaite JR, Stuart JK, Mayes JT, et al. Complications and monitoring of OKT3 therapy. Am J Kidney Dis. 1988;11:112–119
  66. Tilney NL, Kohler TR, Strom TB. Cerebromeningitis in immunosuppressed recipients of renal allografts. Ann Surg. 1982;195:104–109
  67. Wu G, Vilchez RA, Eidelman B, et al. Cryptococcal meningitis: an analysis among 5,521 consecutive organ transplant recipients. Transpl Infect Dis. 2002;4:183–188
  68. Holden FA, Kaczmer JE, Kinahan CC. Listerial meningitis and renal allografts. Postgrad Med. 1980;168:69–74
  69. Iwamoto M, Jernigan DB, Guasch A, et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med. 2003;348:2196–2203
  70. Fukunishi I, Aikawa A, Ohara T, et al. Psychiatric problems among recipients of kidney transplants: a 10-year follow-up. Transpl Proc. 2002;34:2766
  71. Fukunishi I, Sugawara Y, Takayam T, et al. Psychiatric problems in living-related transplantation (i): incidence rate of psychiatric disorders in living-related transplantation. Transplant Proc. 2002;34:2630–2631
  72. Hong JC, Kahan BD. Sirolimus-induced thrombocytopenia and leukopenia in renal transplant recipients: risk factors, incidence, progression, and management. Transplantation. 2000;69:2085–2090
  73. Mix TCH, Kazmi W, Khan S, et al. Anemia: a continuing problem following kidney transplantation. Am J Transplant. 2003;3:1426–1433
  74. Karthikeyan V, Parasuraman R, Shah V, et al. Outcome of plasma exchange therapy in thrombotic microangiopathy after renal transplantation. Am J Transplant. 2003;3:1289–1294
  75. Schwimmer J, Nadasdy TA, Spitalnik PF, et al. De novo thrombotic microangiopathy in renal transplant recipients: a comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy. Am J Kidn Dis. 2003;41:471–479
  76. Reynolds JC, Agodoa LY, Yuan CM, et al. Thrombotic microangiopathy after renal transplantation in the United States. Am J Kidney Dis. 2003;42:1058–1068
  77. Cavallo R, Merlino C, Re D, et al. B19 virus infection in renal transplant recipients. J Clin Virol. 2003;26:361–368
  78. Stein CM, Pincus T. Glucocorticoids. In:  Ruddy S,  Harris ED,  Sledge CB editor. Kelly's Textbook of Rheumatology. 6th ed.. Philadelphia, PA: WB Saunders; 2001;p. 823–840
  79. Vlahakos DV, Marathias KP, Agroyannis B, et al. Posttransplant erythrocytosis. Kidney Int. 2003;63:1187–1194
  80. Nankivell BJ, Allen RDM, O'Connell PJ, et al. Erythrocytosis after renal transplantation: risk factors and relationship with GFR. Clin Transplant. 1995;9:375–382
  81. Remuzzi G, Perico N. Routine renin-angiotensin system blockade in renal transplantation?. Curr Opin Nephrol Hypert. 2002;11:1–10
  82. DeVault GA, King JW, Rohr MS, et al. Opportunistic infections with Strongyloides stercoralis in renal transplantation. Rev Infect Dis. 1990;12:653–671
  83. Heaf JG. Bone disease after renal transplantation. Transplantation. 2003;75:315–325
  84. O'Shaughnessy EA, Dahl DC, Smith CL, et al. Risk factors for fractures in kidney transplantation. Transplantation. 2002;74:362–366
  85. Durieux S, Mercadal L, Orcel P, et al. Bone mineral density and fracture prevalence in long-term kidney graft recipients. Transplantation. 2002;74:496–500
  86. Clive DM. Renal transplant-associated hyperuricemia and gout. J Am Soc Nephrol. 2000;11:974–979
  87. Parasuraman R, Kupin W, Venkat KK, et al. Colchicine-cyclosporine interaction in renal transplant recipients. Presented at the 16th annual scientific meeting of the American Society of Transplant Physicians; May 10-14, 1997; Chicago, IL.
  88. Abbott KC, Oglesby RJ, Agodoa LY. Hospitalized avascular necrosis after renal transplantation in the United States. Kidney Int. 2002;62:2250–2256
  89. Harris ED. Clinical features of rheumatoid arthritis. In:  Ruddy S,  Harris ED,  Sledge CB editor. Kelly's Textbook of Rheumatology. 6th ed.. Philadelphia, PA: WB Saunders; 2001;p. 967–1000
  90. Agarwal S, Owen R. Tendinitis and tendon ruptures in successful renal transplant recipients. Clin Orthop. 1990;252:270–275
  91. Donck JB, Seagert MF, Vanrenterghem YF. Fluoroquinolones and Achilles tendinopathy in renal transplant recipients. Transplantation. 1994;58:736–737
  92. Goffin E, Vande Berg B, Devogelaer JP, et al. Posttransplant syndrome of transient lower limb joint pain: description under a tacrolimus-based immunosuppression. Clin Nephrol. 2003;59:98–105
  93. Abel EA. Cutaneous manifestations of immunosuppression in organ transplant recipients. J Am Acad Derm. 1989;21(2 pt 1):167–179
  94. Iraji F, Kiani A, Shahidi S, et al. Histopathology of skin lesions with warty appearance in renal allograft recipients. Am J Dermatopath. 2002;24:324–325
  95. Euvarard S, Kanitakis J, Claudy A. Medical progress: Skin cancers after organ transplantation. N Engl J Med. 2003;348:1681–1691
  96. Dreno B. Skin cancers after transplantation. Nephrol Dial Transpl. 2003;18:1052–1058
  97. Strumia R, Perini L, Tarroni G, et al. Skin lesions in kidney transplant recipients. Nephron. 1992;62:137–141
  98. Chan MK, Wong KK, Cheng KP, et al. Clinical prevalence and significance of electrolyte disorders in cyclosporine A-treated patients. Transplant Proc. 1988;20(3 suppl 3):705–708
  99. Koc M, Bihorac A, Ozener CI, et al. Severe hyperkalemia in two renal transplant recipients treated with standard doses of trimethoprim-sulfamethoxazole. Am J Kidney Dis. 2000;36:E18
  100. Babarykin D, Adamsone I, Amerika D, et al. Disorders of calcium metabolism at various times after renal transplantation. Ann Transplant. 1999;4:46–53
  101. Levi M. Posttransplant hypophosphatemia. Kidney Int. 2001;59:2377–2387
  102. Heering P, Degenhardt S, Grabensee B. Tubular dysfunction following kidney transplantation. Nephron. 1996;74:501–511
  103. Kasiske BL, Snyder JJ, Gilbertson D, et al. Diabetes mellitus after kidney transplantation in the United States. Am J Transpl. 2003;3:178–185
  104. Coursin DB, Wood KE. Corticosteroid supplementation for adrenal insufficiency. JAMA. 2002;287:236–240

 The authors report this study did not receive any outside funding or support.

 Reprints not available from the authors.

PII: S0196-0644(04)00567-0

doi: 10.1016/j.annemergmed.2004.05.019

Annals of Emergency Medicine
Volume 44, Issue 4 , Pages 330-341 , October 2004

Article Tools